Aura Biosciences, Inc.

NASDAQ:AURA

6.5 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000002.056000000000000000
Cost of Revenue 00.29100.3130.3060.3240.40.30.3280.3230.3020.2960.2560.230.2180.20.2680000
Gross Profit 000-0.313-0.3061.732-0.4-0.3-0.328-0.323-0.302-0.296-0.256-0.23-0.218-0.2-0.2680000
Gross Profit Ratio 000000.842000000000000000
Reseach & Development Expenses 23.34322.33417.03616.87917.05220.2815.42815.1214.40513.15911.2939.518.2767.9796.3656.6324.1853.5432.855.3146.335
General & Administrative Expenses 5.6925.4736.1965.8835.2614.5035.065.1565.0394.4544.7624.3064.5353.6482.532.1691.7421.3660.7810.8411.176
Selling & Marketing Expenses 0000-0.306-0.324000000000000000
SG&A 5.6925.4736.1965.8834.9554.1795.065.1565.0394.4544.7624.3064.5353.6482.532.1691.7421.3660.7810.8411.176
Other Expenses 0000-0.032-0.026-0.005-0.032-0.013-0.008-0.007-0.005000.052000000
Operating Expenses 29.03527.51623.23222.76222.00724.45920.48820.27619.44417.61316.05513.81612.81111.6278.8958.8015.9274.9093.6316.1557.511
Operating Income 0-27.807-23.232-22.762-22.313-24.783-18.512-20.276-19.444-17.613-16.055-13.816-12.811-11.627-8.895-8.801-5.927-4.909-3.631-6.155-7.511
Operating Income Ratio 00000-12.054000000000000000
Total Other Income Expenses Net 01.9972.2332.4252.6532.7891.9761.9771.9781.0540.1540.348-0.024-0.0070.057-0.05100.0020-0.001-0.001
Income Before Tax -27.465-25.81-20.999-20.337-19.66-21.994-18.512-18.299-17.466-16.559-15.901-13.468-12.835-11.634-8.838-8.852-5.927-4.907-3.631-6.156-7.512
Income Before Tax Ratio 00000-10.697000000000000000
Income Tax Expense -0.0180.0240.04300.0460.137-0.348-2.009-2.30625.249-0.154-0.3530.024-0.223-0.0570.051-0.083001.9271.927
Net Income -27.483-25.834-21.042-20.337-19.706-22.131-18.512-18.299-15.16-41.808-15.747-13.468-12.859-11.634-8.838-8.852-5.927-4.907-3.631-8.083-9.439
Net Income Ratio 00000-10.764000000000000000
EPS -0.55-0.52-0.42-0.41-0.4-0.5-0.48-0.48-0.4-1.31-0.54-0.46-0.44-0.42-0.32-0.45-0.3-0.25-0.19-22.15-27.28
EPS Diluted -0.55-0.52-0.42-0.41-0.4-0.5-0.48-0.48-0.4-1.31-0.54-0.46-0.44-0.42-0.32-0.45-0.3-0.25-0.19-22.13-27.27
EBITDA 0-27.516-22.919-22.449-22.007-24.459-20.145-19.976-19.116-17.29-15.753-13.52-12.555-11.397-8.679-8.601-5.742-4.683-3.399-5.964-7.329
EBITDA Ratio 00000-11.896000000000000000